PRICE T ROWE ASSOCIATES INC /MD/
Position in ALDX — Aldeyra Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in ALDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$74,743
-$49,931 QoQ
Shares Held
35,091
-52.4% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 108 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. ALDX ranks #290 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in ALDX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74,743 | 35,091 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $124,674 | 73,772 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $332,877 | 64,262 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $335,447 | 64,262 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $186,455 | 48,683 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $201,727 | 35,083 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $160,203 | 32,105 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $299,802 | 55,622 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $160,445 | 48,473 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $157,852 | 48,273 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $157,342 | 44,827 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $266,478 | 39,892 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $328,468 | 39,150 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $492,398 | 49,587 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $345,125 | 49,587 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $183,626 | 34,387 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $180,786 | 45,310 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $206,087 | 46,364 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $148,256 | 37,064 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $98,019 | 11,164 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $127,621 | 11,264 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||